Specifically, a tissue-associated antigen is administered to the mammal which serves to shift the pathogenic Th1 response associated with pathological immunity toward a protective Th2 response.
These molecules are used to inhibit angiogenesis or treat a disease or condition in which angiogenesis is pathogenic.
A live attenuated derivative of a pathogenic bacterium intended for use as a vaccine
The use of such conjugates as immunogens for the production of antibodies that specifically bind to the pathogenic form of a prion protein is revealed.
Compositions and methods are provided for using tyrosine kinase inhibitors to treat pathogenic infection.
The treated monocytes may be co-incubated with disease effector agents, which may be phagocytized by the immature dendritic cells.
The invention further relates to the use of a method for detecting physiological or pathological blood vessel formation wherein said use is for monitoring a disease process; a healing process; or a response to a disease therapy.